NICE Guidance on Attention Deficit Hyperactivity Disorder has recently been published. Follow on letters in the BMJ (BMJ 2008; 337:a2287 and BMJ 2008; 337:a2284) draw attention to the risk of diversion and abuse of methylphenidate and the flimsy nature of the evidence on which the guidance to prescribe stimulants as a first line treatment in those with "severe" ADHD.
Clearly the management of this condition remains controversial and prescribers need to bear in mind the risks involved.
About Me
- GPonLine
- I work in primary care. Please remember that the links might not work if you don't have access to the journals. Also, I don't accept any responsibility for you following any advice that appears here or in the links.
No comments:
Post a Comment